Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The GLP-1 agonist exenatide is associated with improved adherence to health behavior and lifestyle treatment in adolescents with obesity, a randomized controlled trial.

Obesity facts·2026
Same author

Geno2pheno: recombination detection for HIV-1 and HEV subtypes.

NAR molecular medicine·2025
Same author

Immunophenotyping of Patients With Rheumatoid Arthritis Reveals Difference in CD27<sup>+</sup>IgD<sup>+</sup> Unswitched Memory B Cell Profiles.

Mediators of inflammation·2025
Same author

Association of Lifestyle-Induced Weight Loss With Gene Expression in Subcutaneous Adipose Tissue in Metabolic Syndrome.

Journal of diabetes·2025
Same author

Biological databases in the age of generative artificial intelligence.

Bioinformatics advances·2025
Same author

Declining trends in the incidence of Parkinson's disease: A cohort study in Germany.

Journal of Parkinson's disease·2025
Same journal

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

BMC bioinformatics·2026
Same journal

NAP: an open source pipeline for cross-domain microbiome profiling using Nanopore sequencing-derived amplicon data.

BMC bioinformatics·2026
Same journal

SurvGME: an R package for survival analysis with graphical and measurement error models.

BMC bioinformatics·2026
Same journal

SimMapNet: a Bayesian framework for gene regulatory network inference using gene ontology similarities as external hint.

BMC bioinformatics·2026
Same journal

Dual channel drug-drug interactions extraction based on cross attention.

BMC bioinformatics·2026
Same journal

FeSseqdb: a curated sequence-level database and interpretable machine learning framework for identifying iron-sulfur proteins.

BMC bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Predicting MHC class I epitopes in large datasets.

Kirsten Roomp1, Iris Antes, Thomas Lengauer

  • 1Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, 66123 Saarbruecken, Germany.

BMC Bioinformatics
|February 19, 2010
PubMed
Summary
This summary is machine-generated.

Computational methods accurately predict peptide-MHC binding, especially for strong binders and non-binders. Artificial neural networks performed best, though intermediate binders remain challenging for all prediction tools.

More Related Videos

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Related Experiment Videos

Last Updated: Jun 16, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Area of Science:

  • Immunoinformatics
  • Computational Biology
  • Peptide-MHC Binding Prediction

Background:

  • Experimental screening of peptide-MHC binding is resource-intensive due to vast peptide sequence possibilities and MHC polymorphism.
  • Computational prediction of peptide-MHC binding is crucial for efficient selection of peptides for experimental screening.

Purpose of the Study:

  • To evaluate the performance of four diverse MHC Class I prediction methods.
  • To assess prediction accuracy using large peptide binding datasets from the Immune Epitope Database and Analysis resource (IEDB).

Main Methods:

  • Analysis of four distinct MHC Class I prediction methodologies.
  • Testing on three datasets with varying IC50 cutoff criteria for binder/non-binder classification.
  • Evaluation of prediction robustness based on allele representation in datasets.

Main Results:

  • The best prediction performance was observed using datasets comprising strong binders (IC50 < 10 nM) and clear non-binders (IC50 > 10,000 nM).
  • Prediction robustness was achieved for alleles with sufficiently large (>200) and balanced sets of binders and non-binders.
  • All tested methods demonstrated good to excellent performance on comprehensive datasets.

Conclusions:

  • Artificial neural network-based methods exhibited superior performance compared to other evaluated approaches.
  • All prediction methods encountered significant challenges in accurately categorizing intermediate peptide-MHC binders.